Hutchmed Regulatory News (HCM)

23 Mar 2007 07:00

Hutchison China Meditech Limited23 March 2007 Hutchison China MediTech Limited (AIM: HCM) Director's Shareholding London: Friday, 23 March 2007: Hutchison China MediTech Limited ("Chi-Med") wasinformed on 22 March 2007 that Mr. Christian Hogg, Executive Director and ChiefExecutive Officer of Chi-Med, purchased 100,000 ordinary shares of US$1 each inChi-Med (the "Shares") at a price of 172p each on 22 March 2007. Following this purchase, Mr. Hogg is beneficially interested in 100,000 Shares,representing approximately 0.2% of the current issued share capital of Chi-Med. Ends Enquiries Chi-Med Telephone: +852 2121 8200 Christian Hogg, CEO Citigate Dewe Rogerson Telephone: +44 (0) 20 7638 9571 Anthony Carlisle Mobile: +44 (0) 7973 611 888Yvonne Alexander Mobile: +44 (0) 7866 610 682 About Chi-Med Chi-Med is the holding company of a pharmaceutical and healthcare group basedprimarily in China and was admitted to trading on the Alternative InvestmentMarket of the London Stock Exchange in May 2006. Chi-Med is focused onresearching, developing, manufacturing, and selling pharmaceuticals, healthsupplements and other consumer health and personal care products derived fromTraditional Chinese Medicine and botanical ingredients. Chi-Med is majority owned by Hutchison Whampoa Limited, an internationalcorporation listed on the Main Board of The Stock Exchange of Hong Kong Limited. This information is provided by RNS The company news service from the London Stock Exchange